Trial intelligence / Profile preview

Rapid vs Slow Intrathecal Dexmedetomidine and Bupivacaine for Inguinal Hernia Repair

NCT06253260Completed

Sponsor
Cairo University
Start
Feb 2024
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Duration of postoperative analgesia at 24 hours. Started Feb 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06253260.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06253260.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call